 |
市場調查報告書
商品編碼
1342819
全球銅綠假單胞菌感染治療市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測Global Pseudomonas Aeruginosa Infection Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
||||||
全球銅綠假單胞菌感染治療市場需求預計將從 2022 年的 45.2 億美元增至 2030 年的近 88.2 億美元，2023-2030 年研究期間年複合成長率為 8.72%。
銅綠假單胞菌是一類可在手術後引起個體感染的細菌。這可能會感染血液、肺部或任何其他身體部位。銅綠假單胞菌治療可能涉及許多有助於減輕個體病情的藥物、療法和程序。抗生素和其他藥物通常用於治療銅綠假單胞菌感染。
市場動態：
由於全球胃腸道感染、尿路感染和呼吸系統感染等院內感染的發病率和患病率不斷增加，銅綠假單胞菌感染治療市場可能會出現顯著成長。此外，由於銅綠假單胞菌的流行以及人們對該疾病認知的提高，預計該市場將大幅成長。儘管如此，在臨床試驗中採用擴張策略和強大的新療法管道可以為市場參與者提供充足的機會。
該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球銅綠假單胞菌感染治療市場的各個細分市場進行了包容性評估。銅綠假單胞菌感染治療行業的成長和趨勢為本研究提供了整體方法。
區域分析：
本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的銅綠假單胞菌感染治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。銅綠假單胞菌感染治療市場的主要參與者包括艾爾建、梯瓦製藥工業有限公司、輝瑞公司、盧平製藥公司、阿斯利康、默克公司、百時美施貴寶公司、楊森製藥公司。包括對競爭格局的整體看法，包括各種戰略發展，例如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
目錄
第一章：前言
- 報告說明
- 客觀的
- 目標受眾
- 獨特的銷售主張 (USP) 和產品
- 研究範圍
- 研究方法論
- 市場研究過程
- 市場研究方法論
第 2 章：執行摘要
- 市場亮點
- 全球市場概況
第 3 章：銅綠假單胞菌感染治療 - 行業分析
- 簡介 - 市場動態
- 市場促進因素
- 市場限制
- 機會
- 行業動態
- 波特五力分析
- 市場吸引力分析
- 按藥物類型分類的市場吸引力分析
- 按藥物類型分類的市場吸引力分析
- 按給藥途徑進行的市場吸引力分析
- 按配銷通路分類的市場吸引力分析
- 市場吸引力分析：按地區
第 4 章：價值鏈分析
- 價值鏈分析
- 原料分析
- 原料清單
- 原料廠商清單
- 主要原料價格走勢
- 潛在買家名單
- 行銷管道
- 直效行銷
- 間接行銷
- 行銷管道發展趨勢
第 5 章：COVID-19 爆發的影響分析
第 6 章：全球銅綠假單胞菌感染治療市場分析：按藥物類型
- 按藥物類型概述
- 歷史和預測數據
- 按藥物類型分析
- 單一療法
- 聯合療法
第 7 章：全球銅綠假單胞菌感染治療市場分析：按藥物類型
- 按藥物類型概述
- 歷史和預測數據
- 按藥物類型分析
- 氨基糖苷類
- 頭孢菌素
- 碳青黴烯類
- 單菌醯胺
- 其他
第 8 章：全球銅綠假單胞菌感染治療市場分析：按給藥途徑
- 按給藥途徑概述
- 歷史和預測數據
- 按給藥途徑分析
- 鼻腔
- 口服
- 靜脈
第 9 章：全球銅綠假單胞菌感染治療市場分析：按配銷通路
- 按配銷通路分類的概覽
- 歷史和預測數據
- 按配銷通路分析
- 醫院藥房
- 零售藥店
- 網上藥店
第 10 章：全球銅綠假單胞菌感染治療市場分析：按地理位置
- 區域展望
- 介紹
- 北美銷售分析
- 概述、歷史和預測銷售分析
- 北美按細分市場銷售分析
- 北美按國家/地區銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
- 歐洲銷售分析
- 概述、歷史和預測銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家/地區銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
- 亞太地區銷售分析
- 概述、歷史和預測銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 亞太地區其他地區銷售分析
- 拉丁美洲銷售分析
- 概述、歷史和預測銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家/地區銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
- 中東和非洲銷售分析
- 概述、歷史和預測銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析
第 11 章：銅綠假單胞菌感染治療公司的競爭格局
- 銅綠假單胞菌感染治療市場競爭
- 夥伴關係/協作/協議
- 併購
- 新產品發布
- 其他發展
第 12 章：公司簡介
- 頂級公司股票分析
- 市場集中度
- Allergan
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Teva Pharmaceutical Industries Ltd.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Pfizer Inc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Lupin Pharmaceuticals Inc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- AstraZeneca
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Merck & Co. Inc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Bristol-Myers Squibb Co.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Janssen Pharmaceuticals Inc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內
The global demand for Pseudomonas Aeruginosa Infection Treatment Market is presumed to reach the market size of nearly USD 8.82 BN by 2030 from USD 4.52 BN in 2022 with a CAGR of 8.72% under the study period 2023 - 2030.
Pseudomonas aeruginosa is a class of bacteria that can cause infections in individuals after a surgery. This can infect blood, lungs, or any other body part. Pseudomonas aeruginosa treatment may involve a number of drugs, therapies, and procedures that help lessen an individual's condition. Antibiotics and other medications are typically used to treat Pseudomonas aeruginosa infections.
MARKET DYNAMICS:
The pseudomonas aeruginosa infection treatment market is likely to experience remarkable growth owing to the increasing incidence and prevalence of hospital-acquired infections such as gastrointestinal infections, urinary tract infections, and respiratory system infections across the globe. Additionally, the market is estimated to increase significantly owing to the prevalence of pseudomonas aeruginosa and the surge in awareness about the disease. Nonetheless, adopting expansion strategies and a robust pipeline of new therapies in clinical trials could provide ample opportunities for market players.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pseudomonas aeruginosa infection treatment. The growth and trends of pseudomonas aeruginosa infection treatment industry provide a holistic approach to this study.
MARKET SEGMENTATION:
This section of the pseudomonas aeruginosa infection treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Medication Type
- Monotherapy
- Combination Therapy
By Drug Type
- Aminoglycoside
- Cephalosporin
- Carbapenem
- Monobactam
- Others
By Route Of Administration
- Nasal
- Oral
- Intravenous
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
REGIONAL ANALYSIS:
This section covers the regional outlook, which accentuates current and future demand for the Pseudomonas Aeruginosa Infection Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pseudomonas aeruginosa infection treatment market include Allergan, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Lupin Pharmaceuticals Inc., AstraZeneca, Merck & Co. Inc., Bristol-Myers Squibb Co., Janssen Pharmaceuticals Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . PSEUDOMONAS AERUGINOSA INFECTION TREATMENT - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Medication Type
- 3.7.2 Market Attractiveness Analysis By Drug Type
- 3.7.3 Market Attractiveness Analysis By Route Of Administration
- 3.7.4 Market Attractiveness Analysis By Distribution Channel
- 3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
6 . GLOBAL PSEUDOMONAS AERUGINOSA INFECTION TREATMENT MARKET ANALYSIS BY MEDICATION TYPE
- 6.1 Overview by Medication Type
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Medication Type
- 6.4 Monotherapy Historic and Forecast Sales by Regions
- 6.5 Combination Therapy Historic and Forecast Sales by Regions
7 . GLOBAL PSEUDOMONAS AERUGINOSA INFECTION TREATMENT MARKET ANALYSIS BY DRUG TYPE
- 7.1 Overview by Drug Type
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Drug Type
- 7.4 Aminoglycoside Historic and Forecast Sales by Regions
- 7.5 Cephalosporin Historic and Forecast Sales by Regions
- 7.6 Carbapenem Historic and Forecast Sales by Regions
- 7.7 Monobactam Historic and Forecast Sales by Regions
- 7.8 Others Historic and Forecast Sales by Regions
8 . GLOBAL PSEUDOMONAS AERUGINOSA INFECTION TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
- 8.1 Overview by Route Of Administration
- 8.2 Historical and Forecast Data
- 8.3 Analysis by Route Of Administration
- 8.4 Nasal Historic and Forecast Sales by Regions
- 8.5 Oral Historic and Forecast Sales by Regions
- 8.6 Intravenous Historic and Forecast Sales by Regions
9 . GLOBAL PSEUDOMONAS AERUGINOSA INFECTION TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL
- 9.1 Overview by Distribution Channel
- 9.2 Historical and Forecast Data
- 9.3 Analysis by Distribution Channel
- 9.4 Hospital Pharmacies Historic and Forecast Sales by Regions
- 9.5 Retail Pharmacies Historic and Forecast Sales by Regions
- 9.6 Online Pharmacies Historic and Forecast Sales by Regions
10 . GLOBAL PSEUDOMONAS AERUGINOSA INFECTION TREATMENT MARKET ANALYSIS BY GEOGRAPHY
- 10.1. Regional Outlook
- 10.2. Introduction
- 10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
- 10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
- 10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. Rest Of Asia Pacific Sales Analysis
- 10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
- 10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis
11 . COMPETITIVE LANDSCAPE OF THE PSEUDOMONAS AERUGINOSA INFECTION TREATMENT COMPANIES
- 11.1. Pseudomonas Aeruginosa Infection Treatment Market Competition
- 11.2. Partnership/Collaboration/Agreement
- 11.3. Merger And Acquisitions
- 11.4. New Product Launch
- 11.5. Other Developments
12 . COMPANY PROFILES OF PSEUDOMONAS AERUGINOSA INFECTION TREATMENT INDUSTRY
- 12.1. Top Company Share Analysis
- 12.2. Market Concentration Rate
- 12.3. Allergan
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
- 12.4. Teva Pharmaceutical Industries Ltd.
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
- 12.5. Pfizer Inc.
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
- 12.6. Lupin Pharmaceuticals Inc.
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
- 12.7. AstraZeneca
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
- 12.8. Merck & Co. Inc.
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
- 12.9. Bristol-Myers Squibb Co.
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
- 12.10. Janssen Pharmaceuticals Inc.
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- Analysis by Medication Type (USD MN)
- Monotherapy Market Sales by Geography (USD MN)
- Combination Therapy Market Sales by Geography (USD MN)
- Analysis Market by Drug Type (USD MN)
- Aminoglycoside Market Sales by Geography (USD MN)
- Cephalosporin Market Sales by Geography (USD MN)
- Carbapenem Market Sales by Geography (USD MN)
- Monobactam Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis by Route Of Administration (USD MN)
- Nasal Market Sales by Geography (USD MN)
- Oral Market Sales by Geography (USD MN)
- Intravenous Market Sales by Geography (USD MN)
- Analysis by Distribution Channel (USD MN)
- Hospital Pharmacies Market Sales by Geography (USD MN)
- Retail Pharmacies Market Sales by Geography (USD MN)
- Online Pharmacies Market Sales by Geography (USD MN)
- Global Pseudomonas Aeruginosa Infection Treatment Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Pseudomonas Aeruginosa Infection Treatment Report
- Market Research Process
- Market Research Methodology
- Global Pseudomonas Aeruginosa Infection Treatment Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Medication Type
- Market Attractiveness Analysis by Drug Type
- Market Attractiveness Analysis by Route Of Administration
- Market Attractiveness Analysis by Distribution Channel
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Medication Type (USD MN)
- Monotherapy Market Sales by Geography (USD MN)
- Combination Therapy Market Sales by Geography (USD MN)
- Global Market Analysis by Drug Type (USD MN)
- Aminoglycoside Market Sales by Geography (USD MN)
- Cephalosporin Market Sales by Geography (USD MN)
- Carbapenem Market Sales by Geography (USD MN)
- Monobactam Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by Route Of Administration (USD MN)
- Nasal Market Sales by Geography (USD MN)
- Oral Market Sales by Geography (USD MN)
- Intravenous Market Sales by Geography (USD MN)
- Global Market Analysis by Distribution Channel (USD MN)
- Hospital Pharmacies Market Sales by Geography (USD MN)
- Retail Pharmacies Market Sales by Geography (USD MN)
- Online Pharmacies Market Sales by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Top Company Share Analysis
